Founder & COOJon is a former international magazine editor with a strong background in business publications (print and digital) in the Middle East and Australia.
Cytokinetics (NASDAQ:CYTK) announced that its drug MYQORZO (aficamten) has received approval from the National Medical Products Administration (NMPA) in China for the treatment of adults with NYHA class II-III obstructive hypertrophic cardiomyopathy.
Warner Bros. Discovery (NASDAQ:WBD) has announced that its Board of Directors has unanimously rejected the tender offer launched by Paramount Skydance (NASDAQ:PSKY) on December 8, 2025.
Sinclair (NASDAQ:SBGI) issued a statement today in response to The E.W. Scripps Company (NASDAQ:SSP) rejecting its proposal for a potential merger.
Veru (NASDAQ:VERU) announced its fiscal 2025 results and provided updates on its clinical development of enobosarm for obesity treatment on December 17, 2025.
Mercantile Bank Corporation (NASDAQ:MBWM) and Eastern Michigan Financial Corporation announced on Dec. 16, 2025, that they have received approval from the Federal Reserve Bank of Chicago for their proposed merger.
111 (NASDAQ:YI) today reported its third-quarter 2025 unaudited financial results, showcasing a strategic pivot towards an asset-light model to bolster cash flow and liquidity.
Securitise plans to launch real, regulated stocks directly onchain, aiming to bridge traditional equities with blockchain infrastructure as tokenisation gains momentum.
GenusPlus Group (ASX:GNP) has confirmed it will proceed with construction on the Hunter-Central Coast Renewable Energy Zone sub-transmission line.
Neurotech International (ASX: NTI) received binding commitments from investors for approximately $4 million.
IperionX (ASX:IPX) has achieved ISO 9001 certification for its titanium production and manufacturing operations at its Virginia titanium manufacturing campus.
